首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1904319

胰岛素笔市场规模、份额及成长分析（按类型、应用和地区划分）－2026-2033年产业预测

Insulin Pens Market Size, Share, and Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，胰岛素笔市场规模将达到 13.1 亿美元，到 2025 年将达到 13.9 亿美元，到 2033 年将达到 22.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.26%。

全球胰岛素笔市场正经历强劲增长，这主要得益于糖尿病患者数量的不断增加以及他们对胰岛素笔这种便捷易用的给药方式日益增长的偏好。胰岛素笔因其易用性、剂量精准和便携性而广受糖尿病患者的欢迎。糖尿病患者数量的成长，尤其是在开发中国家，以及人们对胰岛素给药益处的认识不断提高，都推动了这个市场的扩张。记忆功能和蓝牙连接等技术创新正在提升胰岛素笔的易用性和改善患者的治疗效果。然而，高成本的成本，尤其是高端型号的价格，阻碍了胰岛素笔在低收入地区的广泛应用。此外，医疗基础设施的匮乏和严格的监管要求也构成了进一步的障碍，迫使製造商在研发和合规方面投入大量资金。

胰岛素笔市场成长要素

胰岛素笔市场的成长主要得益于此类设备技术的不断创新。蓝牙连结、记忆功能以及智慧胰岛素笔的出现等特性，正在提升患者的整体体验，进而改善治疗效果。这些进步不仅为使用者带来便利和实用功能，还有助于更好地管理糖尿病。这些先进工具的日益普及，推动了病患和医疗服务提供者的需求，进而带动了胰岛素笔的市场需求。这一趋势凸显了科技在变革糖尿病管理解决方案方面所扮演的重要角色。

胰岛素笔市场的限制因素

由于部分族群对针头和自行注射存在恐惧，胰岛素笔市场面临一些挑战。这种恐惧通常被称为针头恐惧症，会阻碍胰岛素笔的接受度和规律使用，导致患者因不愿意自行注射而犹豫不决。因此，许多患者可能会寻求替代方案。这种不愿意自行注射的心理会对治疗依从性和整体糖尿病管理产生重大影响，使其成为胰岛素笔市场成长的一个显着阻碍因素。

胰岛素笔市场趋势

胰岛素笔市场正呈现出显着的客製化和个人化趋势，反映出消费者期望的不断变化，他们希望获得能够满足自身个人化需求和偏好的产品。製造商正日益为用户提供多种选择，包括不同的颜色、剂量设置，甚至是个人化的品牌元素。这一趋势不仅提升了用户参与度，也提高了患者满意度，因为客製化的解决方案能够更有效地管理糖尿病。因此，可客製化胰岛素笔的广泛应用有望推动市场成长，增强患者与其血糖管理工具之间的联繫，并最终有助于改善患者的健康状况。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Ypsomed Holding AG
BD（Becton, Dickinson and Company）
Owen Mumford Ltd
Haselmeier AG
Medtronic plc
Emperra GmbH E-Health Technologies
Diamesco Co., Ltd.
MANNKind Corporation
Jiangsu Delfu Medical Device Co., Ltd.
Pendiq GmbH
Sensile Medical AG
Injex Pharma AG
Copernicus Sp. z oo
Wockhardt Ltd

结论与建议

简介目录

Product Code: SQMIG35B2138

Insulin Pens Market size was valued at USD 1.31 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.26 Billion by 2033, growing at a CAGR of 6.26% during the forecast period (2026-2033).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing preference for insulin pens as a convenient, user-friendly delivery method. These pens are favored for their ease of use, accurate dosing, and portability, particularly among diabetic patients. The expanding diabetic population, especially in developing nations, along with heightened awareness of insulin delivery benefits fuels this market expansion. Technological innovations, such as memory functions and Bluetooth connectivity, have enhanced usability and patient outcomes. However, challenges such as high costs, especially for advanced models, hinder affordability in low-income areas. Additionally, limited healthcare infrastructure and stringent regulatory requirements pose further obstacles, necessitating significant investments in research, development, and compliance for manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Insulin Pens Market Segments Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Insulin Pens Market

The growth of the insulin pens market is significantly fueled by ongoing technological innovations in these devices. Features such as Bluetooth connectivity, memory capabilities, and the emergence of smart insulin pens are enhancing the overall patient experience and leading to improved treatment outcomes. These advancements not only provide users with added convenience and functionality but also promote better management of diabetes. As these sophisticated tools become increasingly available, their appeal expands among patients and healthcare providers alike, ultimately driving the demand for insulin pens in the market. This trend highlights the importance of technology in transforming diabetes management solutions.

Restraints in the Insulin Pens Market

The Insulin Pens market faces certain challenges due to the apprehension some individuals have towards needles and self-injection. This fear, often termed needle phobia, can hinder acceptance and regular usage of insulin pens, leading to reluctance among patients who are uncomfortable with the idea of injecting themselves. As a result, many may seek alternative methods for insulin delivery that they perceive as less intimidating or more user-friendly. This resistance to self-injection can significantly impact treatment adherence and overall management of diabetes, thereby presenting a noteworthy constraint on the growth of the insulin pen market.

Market Trends of the Insulin Pens Market

The insulin pens market is witnessing a notable trend towards customization and personalization, reflecting a shift in consumer expectations for products that align with individual needs and preferences. Manufacturers are increasingly offering options that allow users to select from various colors, dose settings, and even personalized branding elements. This trend not only enhances user engagement but also drives patient satisfaction, as tailored solutions empower individuals to manage their diabetes more effectively. As a result, the proliferation of customizable insulin pens is expected to bolster market growth and foster a stronger connection between patients and their management tools, ultimately improving health outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies
Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2026-2033)

Market Overview
Reusable Insulin Pens
Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Homecare
Others

Global Insulin Pens Market Size & CAGR (2026-2033)

North America, (Type, End-use)
- US
- Canada
Europe, (Type, End-use)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haselmeier AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diamesco Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MANNKind Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pendiq GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensile Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Injex Pharma AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Copernicus Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments